308 related articles for article (PubMed ID: 11093060)
1. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
2. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
4. [An approach to early genetic alterations in precancerous cells].
Sato N; Nishida M; Noguchi M
Hum Cell; 2000 Sep; 13(3):103-8. PubMed ID: 11197771
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
7. [Genetic analysis of endometriosis and ovarian cancer].
Obata K; Hoshiai H
Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
[No Abstract] [Full Text] [Related]
8. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetic defects in endometriosis.
Thomas EJ; Campbell IG
Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
[TBL] [Abstract][Full Text] [Related]
10. [The malignant potential of ovarian atypical endometriosis].
Guo L; Liu T; Lang J
Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):169-72. PubMed ID: 11866970
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas.
Catasús L; Bussaglia E; Rodrguez I; Gallardo A; Pons C; Irving JA; Prat J
Hum Pathol; 2004 Nov; 35(11):1360-8. PubMed ID: 15668893
[TBL] [Abstract][Full Text] [Related]
12. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
13. ARID1A mutations in endometriosis-associated ovarian carcinomas.
Wiegand KC; Shah SP; Al-Agha OM; Zhao Y; Tse K; Zeng T; Senz J; McConechy MK; Anglesio MS; Kalloger SE; Yang W; Heravi-Moussavi A; Giuliany R; Chow C; Fee J; Zayed A; Prentice L; Melnyk N; Turashvili G; Delaney AD; Madore J; Yip S; McPherson AW; Ha G; Bell L; Fereday S; Tam A; Galletta L; Tonin PN; Provencher D; Miller D; Jones SJ; Moore RA; Morin GB; Oloumi A; Boyd N; Aparicio SA; Shih IeM; Mes-Masson AM; Bowtell DD; Hirst M; Gilks B; Marra MA; Huntsman DG
N Engl J Med; 2010 Oct; 363(16):1532-43. PubMed ID: 20942669
[TBL] [Abstract][Full Text] [Related]
14. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
15. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.
Er TK; Su YF; Wu CC; Chen CC; Wang J; Hsieh TH; Herreros-Villanueva M; Chen WT; Chen YT; Liu TC; Chen HS; Tsai EM
J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer.
Prowse AH; Manek S; Varma R; Liu J; Godwin AK; Maher ER; Tomlinson IP; Kennedy SH
Int J Cancer; 2006 Aug; 119(3):556-62. PubMed ID: 16506222
[TBL] [Abstract][Full Text] [Related]
18. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
19. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of ovarian cancer.
Sanseverino F; D'Andrilli G; Petraglia F; Giordano A
Anal Quant Cytol Histol; 2005 Jun; 27(3):121-4. PubMed ID: 16121632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]